selected scholarly activity
-
conferences
- Cerebral Microbleeds and Cognition in Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes Trial. Stroke. 2018
- Characterization of Patients With Embolic Strokes of Uncertain Source in the Navigate-ESUS Trial. Stroke. 2018
- First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study. Stroke. 2018
- Anticoagulant Re-Initiation Following Intracranial Hemorrhage in Non-Valvular Atrial Fibrillation: Practices and Perceptions of Thrombosis Experts, Neurologists and Neurosurgeons. Haemophilia. 47-48. 2017
- Meeting Health Care Research Needs in a Kimball Integrated Data Warehouse. 2016 IEEE International Conference on Data Science and Advanced Analytics (DSAA). 697-705. 2016
- Warfarin-related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-hospital Mortality. International Journal of Stroke. 6-6. 2016
- Warfarin-Related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-Hospital Mortality. Neurology. 2016
- Warfarin-Related Intracerebral Hemorrhage: Predictors of Hematoma Expansion and In-Hospital Mortality. Neurology. 2016
- Prediction of Recurrent Stroke in Lacunar Stroke Patients: Performance of the Small Vessel Disease (SVD) Score in the SPS3 Trial. Stroke. 2016
- NAVIGATE ESUS: Multicenter, Randomized, Double-Blind, Phase III Trial of Rivaroxaban vs. Aspirin for the Prevention of Recurrent Stroke and Systemic Embolism in Patients with Recent Embolic Stroke of Undetermined Source. Cerebrovascular Diseases. 34-35. 2015
- NAVIGATE ESUS: Phase-III RCT assessing prevention of stroke and systemic embolism in patients with embolic stroke of undetermined source. Journal of the Neurological Sciences. e364-e365. 2015
- Improving access to the stroke prevention clinic by removing triage. International Journal of Stroke. 2-2. 2015
- Most patients in stroke rehab are not eligible for independent walking interventions: Lessons from the IMPACT walking study. International Journal of Stroke. 7-7. 2015
- NAVIGATE ESUS: Multicenter, randomized, double-blind, phase III study of prevention of recurrent stroke and systemic embolism in patients with recent embolic stroke of undetermined source. International Journal of Stroke. 36-37. 2015
- Prevalence of potential minor risk sources of embolism in patients with embolic stroke of undetermined source (ESUS) - A global survey. International Journal of Stroke. 12-12. 2015
- What's new in stroke? The randomized clinical trials of 2012-2014. International Journal of Stroke. 69-70. 2015
- Global survey of the frequency of AF-associated stroke and its detection. International Journal of Stroke. 267-267. 2015
- Cerebral Microbleeds in 1278 Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial. Stroke. 2015
- Frequency Aad Features of Patients With Embolic Strokes of Underdetermined Source (esus): Esus Global Registry. Stroke. 2015
- Abnormal Left Ventricular Geometry in Lacunar Stroke: the SPS3 Trial. Stroke. E259-E259. 2014
- Frequency and Features of Patients with Embolic Stroke of Undetermined Source(ESUS). Stroke. E267-E268. 2014
- Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke. Stroke. E280-E281. 2014
- What About the Other 12 Hours? Development and Pilot Testing of a Novel Program to Increase Walking-Related Practice During Stroke Rehabilitation. Stroke. E286-E286. 2014
- Abnormal left ventricular geometry in lacunar stroke: Spectrum, prevalence and prognosis in the SPS3 Trial. Cerebrovascular Diseases. 134-134. 2014
- Cognitive Impairment in Spanish-speaking Patients with Recent Lacunar Stroke: The SPS3 Trial. Cerebrovascular Diseases. 185-185. 2014
- Effect of Blood Pressure Lowering on Cognition in Patients with Lacunar Stroke. The Secondary Prevention of Small Subcortical Strokes (SPS3) trial.. Cerebrovascular Diseases. 33-33. 2014
- Apixaban Versus Aspirin in Atrial Fibrillation Patients >= 75 Years Old: an Analysis From the AVERROES Trial. Stroke. E187-E187. 2013
- Predictors of Stroke Recurrence in Patients with Recent Lacunar Stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) Trial. Stroke. E180-E180. 2013
- Vitamin K Antagonists versus Antiplatelet Monotherapy and Risk of Subdural Hematoma: Meta-analysis of Randomized Clinical Trials. Stroke. E181-E181. 2013
- Benefits of Dabigatran versus Warfarin in Hypertensive Patients With Atrial Fibrillation: Results From The Re-ly Trial. Circulation. 2013
- Baseline Characteristics And Functional Outcomes Of Pontine And Non-pontine Infarcts: On Behalf Of The Secondary Prevention Of Small Subcortical Strokes (SPS3) Investigators. Stroke. 2013
- Classification, Prognosis and Response to Treatment of Lacunar Strokes Based on Likely Pathogenic Mechanism: The SPS3 Trial. Cerebrovascular Diseases. 122-122. 2013
- Effects of Blood Pressure Targets in Patients with Recent Lacunar Stroke: Results of the SPS3 Trial. Cerebrovascular Diseases. 34-34. 2013
- Enlarge Perivascular Spaces in in Lacunar Stroke Patients; Results of The SPS3 trial. Cerebrovascular Diseases. 69-69. 2013
- The Impact of Blood Pressure Variability on Stroke Recurrence: The SPS3 trial. Cerebrovascular Diseases. 111-111. 2013
- Balancing the Benefits and Risks of Two Doses of Dabigatran Compared with Warfarin in Atrial Fibrillation. Circulation. 2012
- Description of a carotid intervention quality assurance initiative through development of a carotid revascularization performance feedback letter. Stroke. E161-E161. 2012
- Effect of apixaban on all-cause mortality in atrial fibrillation: an imputed placebo analysis. European Heart Journal. 52-52. 2012
- BLEEDING WITH ASPIRIN AND APIXABAN IN PATIENTS UNSUITABLE FOR VITAMIN K ANTAGONIST THERAPY: THE AVERROES STUDY. Journal of the American College of Cardiology. E572-E572. 2012
- THE CHA2DS2-VASC SCORE IDENTIFIES AF PATIENTS WITH A CHADS2 SCORE OF 0 OR 1 TREATED WITH ANTIPLATELET THERAPY WHO ARE UNLIKELY TO BENEFIT FROM ORAL ANTICOAGULANT THERAPY. Journal of the American College of Cardiology. E570-E570. 2012
- Impact of Treatment with Apixaban and Aspirin in Patients with Atrial Fibrillation in Relation to the CHADS2 and CHA2DS2-VASc Scores: the AVERROES Study. Circulation. 2011
- Efficacy and safety of the novel oral factor Xa inhibitor apixaban in atrial fibrillation (AF) patients with chronic kidney disease (CKD): the AVERROES trial. European Heart Journal. 6-6. 2011
- The Short-term Functional Outcome in Patients with Lacunar Stroke. Observations from the SPS3 Study. Stroke. E243-E243. 2011
- Thrombolysis for Acute Stroke in Hemodialysis Patients: International Survey of Expert Opinion. Neurology. A633-A634. 2011
- Patients with Thyroid Cancer on TSH Suppression Have a High Risk of Atrial Fibrillation.. Endocrine Reviews. 2010
- Is There a Relationship Between Metabolic Syndrome and Lacunar Stroke? For the SPS3 Investigators. Stroke. E290-E290. 2010
- Left Ventricular Systolic Dysfunction and the Risk of Stroke in the Cardiovascular Health Study. Neurology. A274-A274. 2009
- Single vs. multiple lacunar infarcts. Are they caused by different diseases? The SPS3 study. Stroke. 626-626. 2008
- Incentives and barriers of patients and physicians for participating in the National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC). Neurology. A77-A77. 2007
- Additive role of plasma von Willebrand factor levels to clinical risk stratification in patients with atrial fibrillation. European Heart Journal. 837-837. 2006
- Effect of underlying risk of stroke on treatment effects in the ACTIVE-W Trial. European Heart Journal. 35-36. 2006
- Atrial fibrillation: Old and new therapies. Journal of the Neurological Sciences. S30-S30. 2005
- BP results from the SPS3 pilot study. American Journal of Hypertension. A3-A3. 2003
- Validation of stroke-risk stratification schemes.. Journal of General Internal Medicine. 264-264. 2003
- Secondary prevention of small subcortical strokes (SPS3) pilot trial: Final results. Stroke. 238-238. 2003
- Predictors of stroke in patients paced for sick sinus syndrome. Circulation. 425-425. 2001
- Phase II Studies of the Glycine Antagonist GV150526 in Acute Stroke. Stroke. 358-365. 2000
- DIFFERENCES IN STROKE BETWEEN HISPANICS AND NON-HISPANICS. Neurology. A461-A461. 1995
- PROSTHETIC VALVE ENDOCARDITIS (PVE) - ANTIBIOTICS, ANTICOAGULATION AND STROKE. Stroke. 145-145. 1988
- RELATIVE IMPORTANCE OF ATRIAL CONTRIBUTION TO CARDIAC-OUTPUT AT VARIOUS LEFT-VENTRICULAR FILLING PRESSURES. Circulation. 214-214. 1976
-
journal articles
- Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials. Canadian Journal of Cardiology. 39:187-197. 2023
- Aspirin Use and Risk of Subdural Hematoma: Updated Meta-Analysis of Randomized Trials. Journal of Stroke and Cerebrovascular Diseases. 30:105911-105911. 2021
- Intracranial Atherosclerotic Plaque and Embolic Stroke of Undetermined Source. Journal of the American College of Cardiology. 77:692-694. 2021
- Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial. Journal of Stroke and Cerebrovascular Diseases. 28:2273-2279. 2019
- FIT for FUNCTION: study protocol for a randomized controlled trial. Trials. 19:39. 2018
- Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial. Journal of Stroke and Cerebrovascular Diseases. 27:1673-1682. 2018
- Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). American Journal of Cardiology. 121:584-589. 2018
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. The Lancet. 391:219-229. 2018
- Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?. Stroke. 48:3408-3412. 2017
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. New England Journal of Medicine. 377:1319-1330. 2017
- Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS). Current Neurology and Neuroscience Reports. 17:64. 2017
- Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions. Annals of Neurology. 82:196-207. 2017
- Embolic Stroke of Undetermined Source. Stroke. 48:867-872. 2017
- The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation. JAMA cardiology. 2:324-324. 2017
- Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients?. Circulation. 135:656-658. 2017
- Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting. American Journal of Medicine. 130:222-228. 2017
- Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant?. Canadian Journal of Cardiology. 33:211-213. 2017
- Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses. Canadian Journal of Cardiology. 32:1108-1116. 2016
- Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke. Stroke. 47:2197-2202. 2016
- Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. American Heart Journal. 178:145-150. 2016
- How good is aspirin for patients with acute brain ischaemia?. Nature Reviews Neurology. 12:434-435. 2016
- Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. International Journal of Stroke. 11:526-533. 2016
- Rapid reversal of haematoma expansion associated with vitamin K antagonists. Lancet Neurology. 15:535-537. 2016
- Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. Age and Ageing. 45:77-83. 2016
- Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke. International Journal of Stroke. 10:1031-1036. 2015
- Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments. Stroke. 46:2987-2990. 2015
- Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction. European Heart Journal. 36:2364-2372. 2015
- What's New in Stroke? Phase III Randomized Clinical Trials of 2012–2014. International Journal of Stroke. 10:790-795. 2015
- Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid stenosis is not the solution. Polskie Archiwum Medycyny Wewnetrznej. 125:363-369. 2015
- Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure. Stroke. 46:667-672. 2015
- Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. European Heart Journal. 36:281-288. 2015
- Intensity and Quality of Warfarin Anticoagulation in Chinese Patients. Stroke. 46:5-6. 2015
- Variability in Spine Surgery Procedures Performed During Orthopaedic and Neurological Surgery Residency Training. Journal of Bone and Joint Surgery. American volume. 96:e196-e196. 2014
- Clinical–MRI Correlations in a Multiethnic Cohort with Recent Lacunar Stroke: The SPS3 Trial. International Journal of Stroke. 9:1057-1064. 2014
- Vorapaxar, Combination Antiplatelet Therapy, and Stroke∗. Journal of the American College of Cardiology. 64:2327-2329. 2014
- Embolic strokes of undetermined source: support for a new clinical construct–Authors' reply. Lancet Neurology. 13:967-967. 2014
- Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial. Stroke. 45:2989-2994. 2014
- Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation. Stroke. 45:2127-2130. 2014
- Vitamin K Antagonists and Risk of Subdural Hematoma. Stroke. 45:1672-1678. 2014
- Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurology. 13:429-438. 2014
- Stroke prevention in atrial fibrillation. Neurology: Clinical Practice. 4:96-98. 2014
- Efficacy and Safety of Warfarin VS. Antiplatelet Therapy in Patients with Systolic Heart Failure and Sinus Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Stroke. 9:199-206. 2014
- Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. Cardiology and Therapy. 2:135-149. 2013
- Direct-Acting Oral Anticoagulants. JAMA Neurology. 70:1483-1484. 2013
- Stroke prevention in older adults with atrial fibrillation. CANADIAN MEDICAL ASSOCIATION JOURNAL. 185:1479-1480. 2013
- Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation. Journal of the American College of Cardiology. 62:900-908. 2013
- Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. The Lancet. 382:507-515. 2013
- Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants. Canadian Journal of Cardiology. 29:S34-S44. 2013
- Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease. Canadian Journal of Cardiology. 29:S71-S78. 2013
- Anticoagulant therapy in acute brain ischaemia. Lancet Neurology. 12:526-527. 2013
- Novel oral anticoagulants in secondary prevention of stroke. Best Practice and Research in Clinical Haematology. 26:131-139. 2013
- (Sample) Size Matters! An Examination of Sample Size From the SPRINT Trial Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients With Tibial Fractures. Journal of Orthopaedic Trauma. 27:183-188. 2013
- Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 6:31-38. 2013
- The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. European Heart Journal. 34:170-176. 2013
- Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin. Stroke. 43:3291-3297. 2012
- Sex, Stroke, and Atrial Fibrillation. JAMA Neurology. 69:1641-1641. 2012
- Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease. Postgraduate Medicine. 124:17-25. 2012
- Anticoagulants in atrial fibrillation patients with chronic kidney disease. Nature Reviews Nephrology. 8:569-578. 2012
- Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease. Journal of Stroke and Cerebrovascular Diseases. 21:429-435. 2012
- Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran. Stroke. 43:1511-1517. 2012
- Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer. Clinical and Investigative Medicine. 35:152-152. 2012
- Reducing the risk of recurrent stroke in patients with AF. Lancet Neurology. 11:479-481. 2012
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Lancet. 379:2352-2363. 2012
- Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves. American Journal of Hematology. 87:S100-S107. 2012
- Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 10:966-968. 2012
- Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurology. 11:225-231. 2012
- Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable. ACP journal club. 155:579-579. 2011
- The Secondary Prevention of Small Subcortical Strokes (SPS3) Study. International Journal of Stroke. 6:164-175. 2011
- Irbesartan in Patients with Atrial Fibrillation. New England Journal of Medicine. 364:928-938. 2011
- Apixaban in Patients with Atrial Fibrillation. New England Journal of Medicine. 364:806-817. 2011
- Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology. 75:1343-1350. 2010
- Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes. 3:277-283. 2010
- The Levels of Inflammatory Markers in the Treatment of Stroke Study (Limits): Inflammatory Biomarkers as Risk Predictors after Lacunar Stroke. International Journal of Stroke. 5:117-125. 2010
- Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment. American Heart Journal. 159:348-353.e1. 2010
- Clopidogrel plus aspirin in atrial fibrillation.. New England Journal of Medicine. 361:1314. 2009
- Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation. New England Journal of Medicine. 360:2066-2078. 2009
- Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation. Stroke. 39:1901-1910. 2008
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. Stroke. 39:1482-1486. 2008
- Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks. Stroke. 39:1399-1400. 2008
- Independent predictors of stroke in patients with atrial fibrillation. Neurology. 69:546-554. 2007
- Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. CD006186. 2007
- Primary prevention of ischemic stroke: a guideline from the American heart association/American stroke association stroke council (vol 113, pg 873, 2006). Circulation. 114:E617-E617. 2006
- Warfarin prevents more strokes than clopidogrel and aspirin in afib.. Journal of Family Practice. 55:753. 2006
- American Stroke Association Guideline Policies. Stroke. 37:1965-1965. 2006
- Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. The Lancet. 367:1903-1912. 2006
- Primary Prevention of Ischemic Stroke. Stroke. 37:1583-1633. 2006
- Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.. Stroke. 37:1583-1633. 2006
- Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. American Heart Journal. 151:1187-1193. 2006
- Headache Improvement Through TMD Stabilization Appliance and Self-management Therapies. Cranio - Journal of Craniomandibular Practice. 24:104-111. 2006
- A simple risk score predicted 7 day stroke risk after transient ischaemic attack. BMJ Evidence-Based Medicine. 11:27-27. 2006
- A simple risk score predicted 7-day stroke risk after transient ischemic attack. ACP journal club. 144:24-24. 2006
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. CD001925. 2005
- Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack. Stroke. 36:2164-2169. 2005
- Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews. 2009:CD001927. 2005
- Intramuscular Hand Neuroprosthesis for Chronic Stroke Survivors. Neurorehabilitation and Neural Repair. 17:109-117. 2003
- Intramuscular hand neuroprosthesis for chronic stroke survivors.. Neurorehabilitation and Neural Repair. 17:109-117. 2003
- Design, Progress and Challenges of a Double-Blind Trial of Warfarin versus Aspirin for Symptomatic Intracranial Arterial Stenosis. Neuroepidemiology. 22:106-117. 2003
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation. New England Journal of Medicine. 345:494-502. 2001
- Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Clinical Respiratory Journal. CD001925. 2000
- Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Clinical Respiratory Journal. CD001927. 2000
- Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation. JAMA Internal Medicine. 158:1316-1316. 1998
- Antithrombotic Therapy for Cerebrovascular Disorders. Chest. 108:444S-456S. 1995
- Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. JAMA Internal Medicine. 154:1449-1457. 1994
- Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies.. Stroke. 18:1107-1112. 1987
- Calcific cerebral emboli and aortic stenosis: detection of computed tomography.. Stroke. 17:619-621. 1986
- Atrial fibrillation and the diagnosis of cardioembolic stroke.. Stroke. 16:1043-1044. 1985
- MITRAL-VALVE PROLAPSE AND RISK OF STROKE - REPLY. Stroke. 14:1011-1012. 1983
- Mechanisms of perioperative cerebral infarction.. Stroke. 13:766-773. 1982
- Practical considerations in antifibrinolytic therapy.. Stroke. 13:722-723. 1982